NEW YORK (360Dx) – Analyte Health said Thursday it has reached a deal to provide certain patients access to IQuity's diagnostic tests.

Qualified patients will have immediate access to IsolateMS ­– IQuity's test to help clinicians decide whether a patient may have multiple sclerosis – through Analyte's Health Test Express website. The test is based on an RNA analytic process dubbed IQIsolate to confirm suspected autoimmune diagnosis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.